Cardiovascular Research
Advancing Cardiovascular Clinical Research
Cardiovascular diseases remain a leading cause of mortality worldwide, requiring innovative and precise clinical research. CenExel partners with sponsors to deliver high-quality cardiovascular trials focused on improving outcomes across diverse patient populations—from early-stage risk factors to complex heart conditions.
Studies Conducted
Across cardiovascular indications
0
+
Trial Participants
Enrolled in the last five years
0
+
Active Sites
Specialized cardiovascular centers
0
Overview
Leading Cardiovascular Clinical Research
Complex cardiovascular trials require deep clinical expertise, advanced diagnostics, and operational excellence. CenExel’s cardiovascular research sites integrate experienced investigators, cutting-edge technology, and patient-centered approaches to ensure efficient and reliable trial execution.
Our teams design and conduct trials across a wide range of cardiovascular conditions, leveraging biomarkers, imaging, and real-world data to support accurate outcomes.
We are committed to improving heart health through innovation and collaboration—supporting studies from early-phase development to large-scale clinical programs.
Conditions Covered
Cardiovascular Conditions We Research
Our cardiovascular research sites support a broad spectrum of conditions—from common heart diseases to complex vascular disorders.
Coronary Artery Disease (CAD)
Heart Failure
Hypertension
Atrial Fibrillation
Peripheral Artery Disease (PAD)
Stroke Prevention
Dyslipidemia
Myocardial Infarction (Heart Attack)
Arrhythmias
Cardiomyopathy
Our Approach
Why Sponsors Choose CenExel for Cardiovascular
Our cardiovascular expertise goes beyond patient enrollment—we provide scientific insight, operational excellence, and reliable data for regulatory success.
01
Cardiology Experts
Our experienced cardiologists and research teams ensure accurate diagnosis, monitoring, and high-quality data across all study phases.
02
Advanced Diagnostics
We utilize cutting-edge imaging, biomarkers, and digital health tools to support precise and efficient trial outcomes.
03
Diverse Patient Access
Access to diverse patient populations across multiple locations ensures inclusive and representative clinical trials.
04
Proven Enrollment Success
Our recruitment strategies consistently meet and exceed enrollment targets while maintaining patient engagement.
Phase Coverage
Supported Trial Phases
CenExel supports early and late-phase cardiovascular clinical trials—from first-in-human studies to Phase IV post-marketing research.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Cardiovascular Task Force
CenExel’s cardiovascular task force brings together specialized investigators, cardiologists, and research professionals to support complex trials. Our teams focus on precision, patient safety, and data integrity across a wide range of cardiovascular conditions and study phases.
Active Sites
15 Sites
CenExel Gaithersburg
CenExel Garden Grove
CenExel Atlanta
CenExel Marlton
CenExel Hollywood
Related Therapeutic Areas
Also in Cardiovascular & Related Areas
Therapeutic Area
Metabolic Disorders
Conditions such as diabetes and obesity that impact cardiovascular health.
Therapeutic Area
Renal (Kidney) Disease
Chronic kidney conditions closely linked with cardiovascular complications.
Therapeutic Area
CNS (Stroke & Neurology)
Neurological conditions like stroke that are directly tied to vascular health.